Log in to save to my catalogue

Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a system...

Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a system...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ece11ab3f5a94ba0b4ac9f71486b5044

Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

About this item

Full title

Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2024-03, Vol.22 (1), p.110-31, Article 110

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Previous randomized controlled trials (RCTs) suggested that gut microbiota-based therapies may be effective in treating autoimmune diseases, but a systematic summary is lacking.
Pubmed, EMbase, Sinomed, and other databases were searched for RCTs related to the treatment of autoimmune diseases with probiotics from inception to June 2022. RevMan 5...

Alternative Titles

Full title

Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ece11ab3f5a94ba0b4ac9f71486b5044

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ece11ab3f5a94ba0b4ac9f71486b5044

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-024-03303-4

How to access this item